Identification of early neurodegenerative pathways in progressive multiple sclerosis.
Journal article
Kaufmann M. et al, (2022), Nat Neurosci
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).
Journal article
Dobson R. et al, (2022), Mult Scler Relat Disord, 63
Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease.
Journal article
Zhu WM. et al, (2022), Brain
Out with the old, in with the new: Could plasma exchange be used to fill a therapeutic gap in neurology?
Journal article
Spencer JI. et al, (2021), J Neurol Sci
Contemporary Neuroscience Core Curriculum for Medical Schools.
Journal article
Gelb DJ. et al, (2021), Neurology
Genes and environment in multiple sclerosis: Impact of temporal changes in the sex ratio on recurrence risks.
Journal article
Sadovnick AD. et al, (2021), Mult Scler
Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach.
Journal article
Yeo T. et al, (2021), Brain Commun, 3
Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships.
Journal article
Geraldes R. et al, (2020), Brain, 143, 2998 - 3012
Leading with inclusion during the COVID-19 pandemic: Stronger together.
Journal article
Warrior L. et al, (2020), Neurology, 95, 537 - 542
The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease.
Journal article
Geraldes R. et al, (2020), Mult Scler
The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease.
Journal article
Geraldes R. et al, (2020), Mult Scler
A blood-based metabolomics test to distinguish relapsing-remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application.
Journal article
Yeo T. et al, (2020), Sci Rep, 10
Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosis.
Journal article
Geraldes R. et al, (2020), J Neurol Neurosurg Psychiatry
Approach to the patient with neurologic disease
Chapter
DE LUCA G. and Griggs R., (2019), Goldman-Cecil Medicine, 2-Volume Set
Sir Hugh Cairns: a pioneering collaborator.
Journal article
Attwood JE. et al, (2019), Acta Neurochir (Wien)
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis.
Journal article
Coe S. et al, (2019), J Neurol Neurosurg Psychiatry, 90, 507 - 513
Multiple sclerosis and the risk of systemic venous thrombosis: A systematic review.
Conference paper
Ahmed O. et al, (2019), Mult Scler Relat Disord, 27, 424 - 430
Rapamycin in ischemic stroke: Old drug, new tricks?
Journal article
Hadley G. et al, (2018), J Cereb Blood Flow Metab
From Nose to Gut - The Role of the Microbiome in Neurological Disease.
Journal article
Bell JS. et al, (2018), Neuropathol Appl Neurobiol
Genes, smoking, and organic solvent exposure: An alarming cocktail for MS risk.
Journal article
Bell JS. and DeLuca GC., (2018), Neurology, 91, 199 - 200